title: Androgen receptor antagonist versus agonist activities of the fungicide vinclozolin relative to hydroxyflutamide.
abstract: The mechanism of antiandrogenic activity of vinclozolin (3-(3,5-dichlorophenyl)-5-methyl-5-vinyloxazolidine-2,4-dione), a dicarboximide fungicide under investigation for its potential adverse effects on human male reproduction, was investigated using recombinant human androgen receptor (AR). The two primary metabolites of vinclozolin in plants and mammals are M1 (2-[[3,5-dichlorophenyl)-carbamoyl]oxy]-2-methyl-3-butenoic acid) and M2 (3',5'-dichloro-2-hydroxy-2-methylbut-3-enanilide). Both metabolites, in a dose-dependent manner, target AR to the nucleus and inhibit androgen-induced transactivation mediated by the mouse mammary tumor virus promoter. M2 is a 50-fold more potent inhibitor than M1 and only 2-fold less than hydroxyflutamide. In the presence of dihydrotestosterone (50 nM), M2 (0.2-10 microM) inhibits androgen-induced AR binding to androgen response element DNA. In the absence of dihydrotestosterone, concentrations of 10 microM M2 or hydroxyflutamide promote AR binding to androgen response element DNA and activation of transcription. Agonist activities of M2 and hydroxyflutamide occur at 10-fold lower concentrations with the mutant AR (Thr877 to Ala) endogenous to LNCaP human prostate cancer cells. The results indicate that androgen antagonists can act as agonists, depending on ligand binding affinity, concentration, and the presence of competing natural ligands.
authors.affiliation: Department of Biology, University of North Carolina, Chapel Hill 27599, USA.
authors.forename: C
authors.initials: C
authors.lastname: Wong
authors.forename: W R
authors.initials: WR
authors.lastname: Kelce
authors.forename: M
authors.initials: M
authors.lastname: Sar
authors.forename: E M
authors.initials: EM
authors.lastname: Wilson
mesh_terms: D059002:Androgen Receptor Antagonists; D000728:Androgens; D000818:Animals; D001667:Binding, Competitive; D002460:Cell Line; D004247:DNA / Q000235:genetics / Q000378:metabolism; D013196:Dihydrotestosterone / Q000494:pharmacology; D005485:Flutamide / Q000031:analogs & derivatives* / Q000494:pharmacology; D005659:Fungicides, Industrial / Q000378:metabolism / Q000633:toxicity*; D006801:Humans; D007700:Kinetics; D008297:Male; D010080:Oxazoles / Q000378:metabolism / Q000633:toxicity*; D011944:Receptors, Androgen / Q000378:metabolism; D011994:Recombinant Proteins / Q000235:genetics / Q000378:metabolism; D012098:Reproduction / Q000187:drug effects; D014158:Transcription, Genetic / Q000187:drug effects; D014162:Transfection; D014407:Tumor Cells, Cultured
chemical_list: D059002:Androgen Receptor Antagonists; D000728:Androgens; D005659:Fungicides, Industrial; D010080:Oxazoles; D011944:Receptors, Androgen; D011994:Recombinant Proteins; D013196:Dihydrotestosterone; C014290:hydroxyflutamide; D005485:Flutamide; D004247:DNA; C025643:vinclozolin